Thye Dirk

Thye Dirk is listed in filings as CEO and CMO at Quince Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 23, 2026, including purchase activity. Recent filings connect the profile to Quince Therapeutics, Inc. (QNCX). The current snapshot covers public activity from Sep 3, 2024 to Jan 23, 2026. Reported amounts are shown as $3.1M to $1.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.